Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC ERGi-USU-6 mesylate | 2756327-67-8 | 95.0% | 338.38 | 10 MM 1 ML
SDP

Catalog No. 5000351529
Encompass_Preferred

ERGi-USU-6 mesylate is an inhibitor of ERG and RIOK2, demonstrating anticancer activity against ERG-positive prostate cancer. It inhibits the growth of ERG positive VCaP cells with an IC50 value of 0.089 μM.

  • Inhibits ERG and RIOK2 (IC50 values: 0.17 and 0.13 μM in VCaP cells).
  • Exhibits anticancer activity against ERG-positive prostate cancer.
  • Inhibits the growth of ERG positive VCaP cells (IC50 value: 0.089 μM).

Catalog No. 50-003-51529 Supplier Medchemexpress LLC Supplier No. HY13989310MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ERGi-USU-6 mesylate is an inhibitor of ERG and RIOK2, demonstrating anticancer activity against ERG-positive prostate cancer. It inhibits the growth of ERG positive VCaP cells with an IC50 value of 0.089 μM.

  • Inhibits ERG and RIOK2 (IC50 values: 0.17 and 0.13 μM in VCaP cells).
  • Exhibits anticancer activity against ERG-positive prostate cancer.
  • Inhibits the growth of ERG positive VCaP cells (IC50 value: 0.089 μM).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.